Precigen Inc

NASDAQ:PGEN   2:42:25 PM EDT
8.93
-0.21 (-2.30%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.60B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$22.23 Million
Adjusted EPS-$0.14
See more estimates
10-Day MA$8.92
50-Day MA$8.29
200-Day MA$5.23
See more pivots

INTREXON CORP Stock, NASDAQ:PGEN

20374 SENECA MEADOWS PARKWAY, GERMANTOWN MD, 20876
United States of America
Phone: 301-556-9900
Number of Employees: 882

Description

Precigen Inc operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. Its technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing; and ActoBiotics platform. It also provides reproductive technologies and other genetic processes to cattle breeders and producers; genetic preservation and cloning technologies; genetically engineered swine for medical and genetic research; biological insect control solutions; technologies for non-browning apple without the use of any flavor-altering chemical or antioxidant additives; commercial aquaculture products; and artwork, children's toys, and novelty goods that are derived from living organisms or enabled by synthetic biology. The company serves health, food, energy, environment, and consumer sectors. The company was formerly known as Genomatix Ltd. and changed its name to Intrexon Corporation in 2005. Their name changed to Precigen Inc in 2020 and was founded in 1998 and is based in Germantown, Maryland.